Skip Navigation

Nicotine & Tobacco Research 2007 9(1):21-32; doi:10.1080/14622200601078509
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Wilt, T. J.
Right arrow Articles by Joseph, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilt, T. J.
Right arrow Articles by Joseph, A. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 Society for Research on Nicotine and Tobacco

Spirometry as a Motivational Tool to Improve Smoking Cessation Rates: A Systematic Review of the Literature

Timothy J. Wilt, M.D., M.P.H., Dennis Niewoehner, M.D., Robert L. Kane, M.D., Roderick MacDonald, M.S. and Anne M. Joseph, M.D., M.P.H.

Minnesota Agency for Healthcare Research and Quality Evidence-based Practice Center and Minneapolis Veterans Affairs (VA) Center for Chronic Disease Outcomes Research and Section of General Medicine
Minneapolis VA Section of Pulmonary Medicine
Minnesota Agency for Healthcare Research and Quality Evidence-based Practice Center, University of Minnesota Center on Aging, University of Minnesota School of Public Health, and University of Minnesota Clinical Outcomes Research Center
Minneapolis VA Center for Chronic Disease Outcomes Research and Section of General Medicine Minneapolis, MN, USA

Correspondence: Timothy J. Wilt, M.D., M.P.H., Minneapolis VA Center for Chronic Disease Outcomes Research, 1 Veterans Drive (111-0), Minneapolis, MN 55417, USA. Tel: +1 (612) 467-2681; Fax: +1 (612) 467-2118; E-mail: tim.wilt{at}med.va.gov


   Abstract

Obtaining spirometric testing and providing those results to individuals who smoke has been advocated as a motivational tool to improve smoking cessation. However, its effectiveness is not known. We conducted a systematic review to determine if this approach improves rates of smoking cessation. Data sources included MEDLINE (1966 to October 2005), the Cochrane Library, and experts in the field. Eligible randomized controlled trials (RCTs) enrolled at least 25 smokers per arm, evaluated spirometry with associated counseling or in combination with other treatments, followed subjects at least 6 months, and provided smoking abstinence rates. Results from nonrandomized studies also were summarized. The primary outcome was patient-reported long-term (at least 6 months) sustained abstinence with biological validation. Additional outcomes included self-reported abstinence and point-prevalence abstinence. Seven RCTs (N=6,052 subjects) met eligibility criteria. Follow-up duration ranged from 9 to 36 months. In six trials, the intervention group received concomitant treatments previously demonstrated to increase cessation independently. The range of abstinence was 3%–14% for control subjects and 7%–39% among intervention groups, statistically significantly in favor of intervention in four studies. The only RCT that assessed the independent contribution of spirometry in combination with counseling demonstrated a nonsignificant 1% improvement in patient-reported point-prevalence abstinence at 12 months in the group that received spirometry plus counseling versus counseling alone (6.5% versus 5.5%). Findings from observational studies were mixed, and the lack of controls makes interpretation problematic. Available evidence is insufficient to determine whether obtaining spirometric values and providing that information to patients improves smoking cessation compared with other smoking cessation methods. Spirometric values are of limited benefit as a predictor of smoking cessation or as a tool to "customize" smoking cessation strategies.

Received: October 6, 2005; Accepted: February 9, 2006
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Anderson, R. Yip, C. I. Henschke, D. F. Yankelevitz, J. S. Ostroff, and D. M. Burns
Smoking Cessation and Relapse during a Lung Cancer Screening Program
Cancer Epidemiol. Biomarkers Prev., December 1, 2009; 18(12): 3476 - 3483.
[Abstract] [Full Text] [PDF]


Home page
J. Med. EthicsHome page
D Kotz, R Vos, and M J H Huibers
Ethical analysis of the justifiability of labelling with COPD for smoking cessation
J. Med. Ethics, September 1, 2009; 35(9): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. Kotz, G. Wesseling, M. J. H. Huibers, and O. C. P. van Schayck
Efficacy of confronting smokers with airflow limitation for smoking cessation
Eur. Respir. J., April 1, 2009; 33(4): 754 - 762.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. Lin, B. Watkins, T. Johnson, J. A. Rodriguez, and M. B. Barton
Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Summary of the Evidence for the U.S. Preventive Services Task Force
Ann Intern Med, April 1, 2008; 148(7): 535 - 543.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
E. Derom, C. van Weel, G. Liistro, J. Buffels, T. Schermer, E. Lammers, E. Wouters, and M. Decramer
Primary care spirometry
Eur. Respir. J., January 1, 2008; 31(1): 197 - 203.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.